【レポートの概要(一部)】
01. Executive Summary
02.List of Abbreviations
03.Scope of the Report
03.1 Market overview
03.2 Product offerings
04.Market Research Methodology
04.1 Market research process
04.2 Research methodology
05.Introduction
06.Overview: OTC Drugs
06.1 Regulatory pathways for OTC approval
06.2 FDA OTC drug approval process
06.2.1 OTC NDA
06.2.2 OTC drug monograph
06.2.3 Gastrointestinal prescription to OTC switch
07.Epidemiology of Gastrointestinal Disorders
08.Market Landscape
08.1 Market overview
08.2 Market size and forecast
08.3 Top predictions
08.4 Five forces analysis
09.Market Segmentation by Therapeutic Class of Drug
09.1.1 Gastric acid reducers
09.1.2 Gastric acid neutralizers
09.1.3 Laxatives
09.1.4 Antidiarrheals
09.1.5 Antiemetics
09.1.6 Others
10.Market Segmentation by Indication
10.1.1 GERD
10.1.2 Constipation
10.1.3 Diarrhea
10.1.4 Nausea caused by motion sickness
10.1.5 Flatulence
11.Geographical Segmentation
11.1 Gastrointestinal OTC drugs market in Americas
11.1.1 Market size and forecast
11.2 Gastrointestinal OTC drugs market in EMEA
11.2.1 Market size and forecast
11.3 Gastrointestinal OTC drugs market in APAC
11.3.1 Market size and forecast
12.Buying Criteria
13.Market Growth Drivers
14.Drivers and their Impact
15.Market Challenges
16.Impact of Drivers and Challenges
17.Market Trends
18.Trends and their Impact
19.Vendor Landscape
19.1 Competitive scenario
19.1.1 Key news
19.1.2 Mergers and acquisitions
19.2 Market share analysis 2014
19.2.1 Bayer
19.2.2 GlaxoSmithKline
19.2.3 Johnson & Johnson
19.2.4 Perrigo
19.2.5 Pfizer
19.2.6 P&G
19.3 Other prominent vendors
20.Key Vendor Analysis
20.1 Bayer
20.1.1 Key facts
20.1.2 Business overview
20.1.3 Business segmentation by revenue 2014
20.1.4 Business segmentation by revenue 2013 and 2014
20.1.5 Geographical segmentation by revenue 2014
20.1.6 Business strategy
20.1.7 Recent developments
20.1.8 SWOT analysis
20.2 GlaxoSmithKline
20.2.1 Key facts
20.2.2 Business overview
20.2.3 Business segmentation by revenue 2014
20.2.4 Business segmentation by revenue 2013 and 2014
20.2.5 Geographical segmentation by revenue 2014
20.2.6 Business strategy
20.2.7 Recent developments
20.2.8 SWOT analysis
20.3 Johnson & Johnson
20.3.1 Key facts
20.3.2 Business overview
20.3.3 Business segmentation by revenue 2014
20.3.4 Business segmentation by revenue 2013 and 2014
20.3.5 Geographical segmentation by revenue 2014
20.3.6 Business strategy
20.3.7 Recent developments
20.3.8 SWOT analysis
20.4 Perrigo
20.4.1 Key facts
20.4.2 Business overview
20.4.3 Business segmentation by revenue 2014
20.4.4 Business segmentation by revenue 2013 and 2014
20.4.5 Geographical segmentation by revenue 2014
20.4.6 Business strategy
20.4.7 Recent developments
20.4.8 SWOT analysis
20.5 Pfizer
20.5.1 Key facts
20.5.2 Business overview
20.5.3 Business segmentation by revenue 2014
20.5.4 Business segmentation by revenue 2013 and 2014
20.5.5 Geographical segmentation by revenue 2014
20.5.6 Business strategy
20.5.7 Key developments
20.5.8 SWOT analysis
20.6 P&G
20.6.1 Key facts
20.6.2 Business overview
20.6.3 Business segmentation by revenue 2014
20.6.4 Business segmentation by revenue 2013 and 2014
20.6.5 Geographical segmentation by revenue 2014
20.6.6 Business strategy
20.6.7 Recent developments
20.6.8 SWOT analysis
21.Other Reports in this Series
[List of Exhibits]
Exhibit 1: Market research methodology
Exhibit 2: Comparison between prescription and OTC drugs
Exhibit 3: Advantages and disadvantages of OTC drugs
Exhibit 4: Ways to establish an OTC drug in different markets
Exhibit 5: Key regulatory bodies for OTC approval
Exhibit 6: FDA OTC drug approval process
Exhibit 7: Comparison of NDA versus OTC monograph process
Exhibit 8: Mechanisms to amend an OTC drug monograph
Exhibit 9: Drugs underwent Rx-to-OTC switch in US
Exhibit 10: Global gastrointestinal OTC drugs market 2014-2019 ($ million)
Exhibit 11: Top predictions in global gastrointestinal OTC drugs market
Exhibit 13: Global gastrointestinal OTC drugs market by therapeutic class of drug
Exhibit 14: Global gastrointestinal OTC drugs market by therapeutic class of drug 2014
Exhibit 15: Global gastrointestinal OTC drugs market by indication
Exhibit 16: Segmentation of global gastrointestinal OTC drugs market by geography 2014
Exhibit 17: Segmentation of global gastrointestinal OTC drugs market by geography 2019
Exhibit 18: Gastrointestinal OTC drugs market in Americas 2014-2019 ($ million)
Exhibit 19: Gastrointestinal OTC drugs market in EMEA 2014-2019 ($ million)
Exhibit 20: Gastrointestinal OTC drugs market in APAC 2014-2019 ($ million)
Exhibit 21: Key takeaways: Bayer
Exhibit 22: Key takeaways: GlaxoSmithKline
Exhibit 23: Key takeaways: Johnson & Johnson
Exhibit 24: Key takeaways: Perrigo
Exhibit 25: Product portfolio matrix of major vendors
Exhibit 26: Key takeaways: Pfizer
Exhibit 27: Key takeaways: P&G
Exhibit 28: Bayer: business segmentation by revenue 2014
Exhibit 29: Bayer: business segmentation by revenue 2013 and 2014 (US$ billion)
Exhibit 30: Bayer: geographical segmentation by revenue 2014
Exhibit 31: GlaxoSmithKline: business segmentation by revenue 2014
Exhibit 32: GlaxoSmithKline: Business segmentation by revenue 2013 and 2014 ($ billion)
Exhibit 33: GlaxoSmithKline: geographical segmentation by revenue 2014
Exhibit 34: Johnson & Johnson: business segmentation by revenue 2014
Exhibit 35: Johnson & Johnson: business segmentation by revenue 2013 and 2014 ($ billion)
Exhibit 36: Johnson & Johnson: geographical segmentation by revenue 2014
Exhibit 37: Perrigo: business segmentation by revenue 2014
Exhibit 38: Perrigo: business segmentation by revenue 2013 and 2014 ($ billion)
Exhibit 39: Perrigo: geographical segmentation by revenue 2014
Exhibit 40: Pfizer: business segmentation by revenue 2014
Exhibit 41: Pfizer: business segmentation by revenue 2013 and 2014 ($ billion)
Exhibit 42: Pfizer: geographical segmentation by revenue 2014
Exhibit 43: P&G: business segmentation by revenue 2014
Exhibit 44: P&G: business segmentation by revenue 2013 and 2014 ($ billion)
Exhibit 45: P&G: geographical segmentation by revenue 2014
【レポート販売概要】
■ タイトル:消化管疾患治療薬(一般用医薬品)の世界市場:胃食道逆流症(GERD)、便秘、下痢、吐気、鼓腸■ 英文:Global Gastrointestinal OTC Drugs Market 2015-2019
■ 発行日:2015年4月15日
■ 調査会社:Technavio
■ 商品コード:IRTNTR5810
■ 調査対象地域:グローバル
- 世界のDairy Food市場におけるM&A動向(2014年2月)Synopsis The report provides a review of the mergers and acquisitions (M&As), partnering deals, and agreements entered into by companies active in the global dairy food market during February 2014. Summary Using this report, dealmakers will effectively gain an insight into deal activity of the global dairy food market throughout the month. Additionally, the report provides an overview of all the p …
- ナノ対応パッケージングの世界市場分析:技術別(アクティブパッケージ、インテリジェント・スマートパッケージ、コントロールリリースパッケージ)、用途別(食品・飲料、医薬品、パーソナルケア・化粧品)、セグメント予測The global nano-enabled packaging market is expected to reach USD 66.30 billion by 2024, according to a new report by Grand View Research, Inc. Increasing investments in developing effective and efficient packaging technologies is excepted to spur market growth. Growing awareness of the benefits, that nano-enabled packaging offer to the food & beverage and pharmaceutical industry is expected to ha …
- 脊髄外傷治療用デバイスの世界市場ABSTRACTAbout Spinal Trauma Devices Spinal trauma refers to a severe injury to the spinal cord. It can occur due to accidents, falls, violence like a gunshot, or infections and requires the fixation of spinal trauma devices to treat bone deformities, facilitate bone fusion, strengthen and stabilize the spinal cord, and prevent further damage and complications. Technavio’s analysts forecast the glo …
- グローバル水可溶性肥料市場分析と予測Water-soluble fertilizers are fertilizers that can be dissolved in water and added or leached out of the soil easily. It is easy to control the precise amount of nutrients available to plants with the help of water-soluble fertilizers. In terms of volume, the water-soluble fertilizers market is estimated to grow at a CAGR of 5.3% from 2013 to 2018, reaching 9,251.2 thousand metric tons by 2018. Th …
- ソース・メジャー・ユニット(SMU)の世界市場予測(~2023年)The overall source measure unit market is projected to witness significant growth during the forecast period. The market is growing due to the increasing demand for electronic testing equipment in end-user industries such as automotive, aerospace & defense, IT & telecommunications, education and government, process industries, and healthcare. The source measure unit market is expected to be valued …
- 4G及び4G以後におけるHetNet導入及び運用戦略Traditional voice centric mobile networks were designed and planned back in the 20th century for a certain type of usage. The subscriber base consisted of users who were mostly making voice calls, both outdoors and indoors, with very consistent usage patterns. The birth of smart wireless devices has created a completely new set of challenges and opportunities for Mobile Network Operators (MNO). Cu …
- 太陽光エネルギーの世界市場:技術別(太陽光発電システムおよび集光型太陽光発電システム)、ソーラーモジュール別(単結晶、多結晶、テルル化カドミウム、アモルファスシリコンセル、その他)、用途別(住宅用、商業用、工業用)、最終用途別(発電、加熱、充電、照明)Solar Energy Market Outlook - 2026 The global solar energy market was valued at $52.5 billion in 2018 and is projected to reach $223.3 billion by 2026, growing at a CAGR of 20.5% from 2019 to 2026. Solar energy is the radiant energy emitted from the sun, which is harnessed by using various technologies such as solar heating, photovoltaic cells, and others. It is an efficient form of unconventional …
- 世界のTFT-LCD市場2015The Global TFT-LCD Industry 2015 Market Research Report is a professional and in-depth study on the current state of the TFT-LCD industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The TFT-LCD market analysis is provided for the international markets including development trends, competitive landscape anal …
- メキシコの患者診察機器市場見通し(~2021)Mexico Patient Examination Devices Market Outlook to 2021 Summary GlobalData’s new report, "Mexico Patient Examination Devices Market Outlook to 2021", provides key market data on the Mexico Patient Examination Devices market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - Stethoscopes and Thermometers. The r …
- 世界の乗用車向け半自律制御市場:アダプティブクルーズコントロール、車線維持支援などAutomotive industry was one of the key industries affected by the economic downturn in 2008 (global sales 68.1 million units) and 2009 (global sales 65.4 million units). However, the scenario has changed since 2010 (global sales 74.6 million units). This upward trend continued in 2011 and 2012. The present global demand for automobiles is increasing at a significant rate, indicating the pace at wh …
- ディスプレイ広告市場におけるリアルタイム入札(Real time bidding)n/a
- Straumann Holding AG:市場シェア分析Straumann Holding AG Market Share Analysis Summary GlobalData’s new report, “Straumann Holding AG Market Share Analysis” provides in-depth information on Straumann Holding AG’s market position in the different medical equipment markets it operates in. The report provides Straumann Holding AG market share information in three key market categories – Dental Implants, Dental Biomaterials and CAD/CAM …
- 坑井仕上げ用装置の世界市場:プロダクション・ケーシング/チュービング、坑井刺激ツール、ウェルヘッド装置、パッカー、ライナーハンガー等About Well Completion Equipment Well completion refers to activities that render a well capable of production. It primarily involves conditioning the well bottom to the required specification. Well completion incorporates steps like running the production casing and tubing, perforation, assembling sand control systems (gravel packing, screens),placing a liner and installing well head equipment (pr …
- 溶剤型コイルコーティングの世界市場2015-2019About Solvent-borne Coil Coatings Coil coatings, also known as prepainted metal coatings, are used to coat metal surfaces before they are shaped into end products. They cause minimal VOC emissions, do not consume a lot of energy, and result in low wastage. They have many advantages over post-painted metal coatings, such as corrosion protection and long-term aesthetic value. Technavio's analysts fo …
- FEC Resources, Inc.:石油・ガスの開発・生産動向及びコスト分析- 2012FEC Resources, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - 2012 Summary FEC Resources, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key …